Literature DB >> 25684669

US adults recommended for weight reduction by 1998 and 2013 obesity guidelines, NHANES 2007-2012.

June Stevens1, Eva Erber Oakkar, Zhaohui Cui, Jianwen Cai, Kimberly P Truesdale.   

Abstract

OBJECTIVE: To determine the number and proportion of American adults recommended for weight loss treatment under the 1998 and 2013 guidelines on the management of overweight and obesity in adults and to compare characteristics of individuals recommended for treatment.
METHODS: A total of 6,692 adult, non-pregnant participants in the National Health and Nutrition Examination Survey 2007-2012 with complete data on demographics, anthropometrics, and biomedical measures were analyzed.
RESULTS: Compared to the 1998 guidelines, the 2013 guidelines increased the number of adults recommended for weight loss treatment by 20.9% from 116.0 million to 140.2 million, making 64.5% of non-pregnant, non-institutionalized US adults candidates for treatment. The new guidelines recommended treatment for a larger proportion of those overweight, having only one risk factor, or having a large waist circumference. Up to 53.4% of adults could be considered for pharmacologic therapy in addition to lifestyle therapy, and up to 14.7% could be considered for bariatric surgery.
CONCLUSIONS: The 2013 guidelines increased the number of adults to be treated with weight loss by 24.2 million, with the increases spread across groups that differ in socio demographic characteristics.
© 2015 The Obesity Society.

Entities:  

Mesh:

Year:  2015        PMID: 25684669     DOI: 10.1002/oby.20985

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  15 in total

Review 1.  Gastrointestinal traits: individualizing therapy for obesity with drugs and devices.

Authors:  Michael Camilleri; Andres Acosta
Journal:  Gastrointest Endosc       Date:  2015-08-10       Impact factor: 9.427

2.  Editorial: Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice?

Authors:  Vivek Kumbhari; Patrick I Okolo
Journal:  Am J Gastroenterol       Date:  2017-03       Impact factor: 10.864

Review 3.  Medical devices for the treatment of obesity.

Authors:  Phong Ching Lee; John Dixon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-12       Impact factor: 46.802

Review 4.  The microbiome-adipose tissue axis in systemic metabolism.

Authors:  Patrick Lundgren; Christoph A Thaiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-18       Impact factor: 4.052

5.  Persistent microbiome alterations modulate the rate of post-dieting weight regain.

Authors:  Christoph A Thaiss; Shlomik Itav; Daphna Rothschild; Mariska T Meijer; Maayan Levy; Claudia Moresi; Lenka Dohnalová; Sofia Braverman; Shachar Rozin; Sergey Malitsky; Mally Dori-Bachash; Yael Kuperman; Inbal Biton; Arieh Gertler; Alon Harmelin; Hagit Shapiro; Zamir Halpern; Asaph Aharoni; Eran Segal; Eran Elinav
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

6.  Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner.

Authors:  Diego Adhemar Jaitin; Lorenz Adlung; Christoph A Thaiss; Assaf Weiner; Baoguo Li; Hélène Descamps; Patrick Lundgren; Camille Bleriot; Zhaoyuan Liu; Aleksandra Deczkowska; Hadas Keren-Shaul; Eyal David; Niv Zmora; Shai Meron Eldar; Nir Lubezky; Oren Shibolet; David A Hill; Mitchell A Lazar; Marco Colonna; Florent Ginhoux; Hagit Shapiro; Eran Elinav; Ido Amit
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

7.  Smartloss: A Personalized Mobile Health Intervention for Weight Management and Health Promotion.

Authors:  Corby K Martin; L Anne Gilmore; John W Apolzan; Candice A Myers; Diana M Thomas; Leanne M Redman
Journal:  JMIR Mhealth Uhealth       Date:  2016-03-16       Impact factor: 4.773

8.  Smartphone applications to aid weight loss and management: current perspectives.

Authors:  Elizabeth F Sutton; Leanne M Redman
Journal:  Diabetes Metab Syndr Obes       Date:  2016-07-18       Impact factor: 3.168

Review 9.  Oxidative Stress and Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases.

Authors:  Cheng-Chieh Chang; Yu-Chun Chang; Wen-Long Hu; Yu-Chiang Hung
Journal:  Oxid Med Cell Longev       Date:  2016-10-11       Impact factor: 6.543

10.  Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines.

Authors:  June Stevens; Eva Erber-Oakkar; Zhaohui Cui; Jianwen Cai; Salim S Virani; Emanuele Di Angelantonio; David Wormser
Journal:  Obesity (Silver Spring)       Date:  2016-05-17       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.